Knowledge (XXG)

GW0742

Source šŸ“

269: 29: 936:
Toral M, GĆ³mez-GuzmĆ”n M, JimĆ©nez R, Romero M, Zarzuelo MJ, Utrilla MP, Hermenegildo C, Cogolludo Ɓ, PĆ©rez-VizcaĆ­no F, GĆ”lvez J, Duarte J (September 2015). "Chronic peroxisome proliferator-activated receptorĪ²/Ī“ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and
620:
Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, Goreham D, Sierra ML, LeGrumelec C, Xu HE, Montana VG, Lambert MH, Willson TM, Oliver WR, Sternbach DD (May 2003). "Novel selective small molecule agonists for peroxisome proliferator-activated receptor Ī“ (PPARĪ“)--synthesis and biological
895:
Paterniti I, Mazzon E, Riccardi L, Galuppo M, Impellizzeri D, Esposito E, Bramanti P, Cappellani A, Cuzzocrea S (July 2012). "Peroxisome proliferator-activated receptor Ī²/Ī“ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice".
1081:
Haskova Z, Hoang B, Luo G, Morgan LA, Billin AN, Barone FC, Shearer BG, Barton ME, Kilgore KS (July 2008). "Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742".
472:
GW0742 has been shown to ameliorate experimentally induced pancreatitis in mice. Additionally, it prevents hypertension in diet induced obese mice, has been investigated as potential antidiabetic drug, and has anti-inflammatory effects.
576:
Haskova Z, Hoang B, Luo G, Morgan LA, Billin AN, Barone FC, et al. (July 2008). "Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742".
1035:
Di Paola R, Esposito E, Mazzon E, Paterniti I, Galuppo M, Cuzzocrea S (August 2010). "GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury".
532:
Smith SA, Monteith GR, Robinson JA, Venkata NG, May FJ, Roberts-Thomson SJ (July 2004). "Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons".
806:
Perez Diaz N, Zloh M, Patel P, Mackenzie LS (January 2016). "In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist properties".
700:
Nandhikonda P, Yasgar A, Baranowski AM, Sidhu PS, McCallum MM, Pawlak AJ, Teske K, Feleke B, Yuan NY, Kevin C, Bikle DD, Ayers SD, Webb P, Rai G, Simeonov A, Jadhav A, Maloney D, Arnold LA (June 2013).
460:
Multiple derivatives of GW0742 core structure have been developed. One of the compounds has the thiazole ring replaced with an oxazole ring inhibited VDR-meditated transcription with IC
41: 351: 443:
It is mixed PPAR-B agonist antagonist depending on its dosage. It has weak activity on multiple nuclear receptors as well. It is antagonistic at androgen receptors and
1509: 1388: 1169: 365: 761: 1153: 492: 420: 393:
InChI=InChI=1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28)
1144: 1962: 703:"Peroxisome proliferation-activated receptor Ī“ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor" 658:"Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin" 988: 1972: 1548: 1535: 1409: 1190: 1982: 385: 809: 1525: 86: 62: 1543: 1404: 1185: 1137: 844:
Teske KA, Rai G, Nandhikonda P, Sidhu PS, Feleke B, Simeonov A, Yasgar A, Jadhav A, Maloney DJ, Arnold LA (October 2017).
1940: 1804: 1794: 1038: 188: 1977: 464:
of 660 nM. Other novel analogues which are more potent than GWO742 with reduced toxicity have been developed as well.
248: 1122: 1479: 1353: 850: 1130: 157: 939: 1967: 1718: 1530: 1328: 1323: 1235: 1992: 1313: 1084: 237: 148: 1728: 511: 1200: 846:"Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on the GW0742 Scaffold" 1997: 1844: 1563: 264: 103: 1766: 1736: 1713: 1708: 1693: 1608: 1583: 1987: 1703: 1648: 1613: 1161: 1109: 1063: 964: 602: 558: 444: 1741: 1434: 1849: 1673: 1668: 1663: 1464: 1454: 1293: 1288: 1225: 1499: 1494: 1363: 1308: 1101: 1055: 1017: 956: 915: 877: 826: 788: 734: 679: 656:
Wagner N, Jehl-PiĆ©tri C, Lopez P, Murdaca J, Giordano C, Schwartz C, et al. (July 2009).
638: 594: 550: 1859: 1839: 1819: 1814: 1638: 1373: 1270: 177: 1834: 1824: 1756: 1688: 1558: 1489: 1414: 1205: 1093: 1047: 1007: 997: 948: 907: 867: 859: 818: 778: 770: 724: 716: 669: 630: 586: 542: 285: 112: 197: 427: 268: 822: 1280: 1012: 983: 872: 845: 783: 756: 729: 702: 634: 1956: 1918: 1908: 1771: 1751: 1746: 1698: 1678: 1474: 1343: 1298: 1113: 1067: 968: 606: 562: 137: 1883: 1878: 1786: 1781: 1761: 1723: 1683: 1658: 1653: 1603: 1459: 1358: 1348: 1338: 1333: 1303: 1275: 707: 952: 1913: 1903: 1893: 1776: 1628: 1618: 1593: 1588: 1578: 1573: 1553: 1429: 1419: 1318: 1265: 1255: 1245: 1215: 1210: 1195: 487: 447:. In silico modelling suggest that it has effects on thyroid hormone receptors. 911: 863: 774: 1923: 1898: 1888: 1469: 1239: 1220: 1097: 590: 327: 168: 28: 1643: 1633: 1568: 1449: 1439: 1260: 1105: 1059: 1021: 984:"Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals" 960: 919: 881: 830: 792: 738: 683: 642: 598: 554: 1623: 1598: 1424: 1250: 1230: 674: 482: 1510: 1389: 1170: 1051: 1002: 1809: 1444: 898: 423: 123: 20: 720: 546: 1378: 228: 657: 217: 1154: 350: 341: 208: 94:-4-methyl-5-thiazolyl]methyl]thio]-2-methyl phenoxy]-acetic acid 1126: 253: 1515:
Tooltip Peroxisome proliferator-activated receptor gamma
1394:
Tooltip Peroxisome proliferator-activated receptor delta
1175:
Tooltip Peroxisome proliferator-activated receptor alpha
373:
FC(F)(F)c3c(F)cc(c1nc(c(s1)CSc2cc(c(OCC(=O)O)cc2)C)C)cc3
757:"Novel VDR antagonists based on the GW0742 scaffold" 1868: 1508: 1387: 1168: 339: 326: 284: 279: 247: 227: 207: 187: 167: 156: 147: 122: 102: 77: 61: 56: 40: 35: 1159:Tooltip Peroxisome proliferator-activated receptor 937:endothelial dysfunction in diet-induced obesity". 1795: 982:Niu HS, Ku PM, Niu CS, Cheng JT, Lee KS (2015). 755:Teske KA, Bogart JW, Arnold LA (February 2018). 136: 931: 929: 111: 750: 748: 695: 693: 1138: 8: 762:Bioorganic & Medicinal Chemistry Letters 623:Bioorganic & Medicinal Chemistry Letters 19: 426:that has been investigated for drug use by 1145: 1131: 1123: 810:Prostaglandins & Other Lipid Mediators 493:Peroxisome proliferator-activated receptor 267: 176: 27: 1011: 1001: 871: 782: 728: 673: 196: 503: 390: 370: 263: 91: 18: 236: 7: 989:Drug Design, Development and Therapy 823:10.1016/j.prostaglandins.2015.12.002 216: 127: 16:PPAR Ī²/Ī“ receptor Agonist compound 14: 1800:Tooltip Selective PPARĪ³ modulator 535:Journal of Neuroscience Research 308: 302: 296: 398:Key:HWVNEWGKWRGSRK-UHFFFAOYSA-N 1963:Drugs not assigned an ATC code 317: 311: 290: 1: 1941:Receptor/signaling modulators 635:10.1016/s0960-894x(03)00207-5 1039:Journal of Leukocyte Biology 953:10.1097/HJH.0000000000000634 1684:Muraglitazar (muroglitazar) 2014: 1973:Drugs developed by GSK plc 1536:15-Deoxy-Ī”-prostaglandin J 912:10.1016/j.surg.2012.02.004 864:10.1021/acscombsci.7b00066 775:10.1016/j.bmcl.2017.12.041 280:Chemical and physical data 1983:Trifluoromethyl compounds 1932: 1480:Tetradecylthioacetic acid 1354:Tetradecylthioacetic acid 1098:10.1007/s00011-007-7157-4 851:ACS Combinatorial Science 591:10.1007/s00011-007-7157-4 381: 361: 82: 26: 512:"Cayman Chemical GW0742" 940:Journal of Hypertension 662:Cardiovascular Research 1719:Perfluorononanoic acid 1329:Perfluorooctanoic acid 1324:Perfluorononanoic acid 1314:Palmitoylethanolamide 1085:Inflammation Research 579:Inflammation Research 1531:5-Oxo-15-hydroxy-ETE 1201:Aluminium clofibrate 1052:10.1189/jlb.0110053 1003:10.2147/DDDT.S95045 23: 1978:Experimental drugs 675:10.1093/cvr/cvp106 1950: 1949: 1309:Oleylethanolamide 721:10.1021/bi400321p 547:10.1002/jnr.20153 406: 405: 352:Interactive image 249:CompTox Dashboard 2005: 1801: 1797: 1559:Arachidonic acid 1516: 1512: 1415:Arachidonic acid 1395: 1391: 1206:Arachidonic acid 1176: 1172: 1160: 1156: 1147: 1140: 1133: 1124: 1118: 1117: 1078: 1072: 1071: 1032: 1026: 1025: 1015: 1005: 979: 973: 972: 933: 924: 923: 892: 886: 885: 875: 841: 835: 834: 803: 797: 796: 786: 752: 743: 742: 732: 715:(24): 4193ā€“203. 697: 688: 687: 677: 653: 647: 646: 617: 611: 610: 573: 567: 566: 529: 523: 522: 520: 518: 508: 439:Pharmacodynamics 354: 334: 319: 313: 310: 304: 298: 292: 272: 271: 257: 255: 240: 220: 200: 180: 160: 140: 130: 129: 115: 31: 24: 22: 2013: 2012: 2008: 2007: 2006: 2004: 2003: 2002: 1953: 1952: 1951: 1946: 1928: 1864: 1799: 1732: 1729:Prostaglandin J 1539: 1514: 1504: 1393: 1383: 1284: 1174: 1164: 1158: 1151: 1121: 1080: 1079: 1075: 1034: 1033: 1029: 981: 980: 976: 935: 934: 927: 894: 893: 889: 858:(10): 646ā€“656. 843: 842: 838: 805: 804: 800: 754: 753: 746: 699: 698: 691: 655: 654: 650: 619: 618: 614: 575: 574: 570: 531: 530: 526: 516: 514: 510: 509: 505: 501: 479: 470: 463: 458: 453: 441: 436: 428:GlaxoSmithKline 411:(also known as 402: 399: 394: 389: 388: 377: 374: 369: 368: 357: 332: 322: 316: 307: 301: 295: 275: 251: 243: 223: 203: 183: 163: 143: 126: 118: 98: 95: 90: 89: 73: 70:Investigational 52: 17: 12: 11: 5: 2011: 2009: 2001: 2000: 1995: 1990: 1985: 1980: 1975: 1970: 1965: 1955: 1954: 1948: 1947: 1945: 1944: 1937: 1933: 1930: 1929: 1927: 1926: 1921: 1916: 1911: 1906: 1901: 1896: 1891: 1886: 1881: 1872: 1870: 1866: 1865: 1863: 1862: 1853: 1852: 1847: 1842: 1837: 1828: 1827: 1822: 1817: 1812: 1807: 1790: 1789: 1784: 1779: 1774: 1769: 1764: 1759: 1754: 1749: 1744: 1739: 1734: 1730: 1726: 1721: 1716: 1711: 1706: 1701: 1696: 1691: 1686: 1681: 1676: 1671: 1666: 1661: 1656: 1651: 1646: 1641: 1636: 1631: 1626: 1621: 1616: 1611: 1606: 1601: 1596: 1591: 1586: 1581: 1576: 1571: 1566: 1561: 1556: 1551: 1546: 1541: 1537: 1533: 1528: 1519: 1517: 1506: 1505: 1503: 1502: 1497: 1492: 1483: 1482: 1477: 1472: 1467: 1462: 1457: 1452: 1447: 1442: 1437: 1432: 1427: 1422: 1417: 1412: 1407: 1398: 1396: 1385: 1384: 1382: 1381: 1376: 1367: 1366: 1361: 1356: 1351: 1346: 1341: 1336: 1331: 1326: 1321: 1316: 1311: 1306: 1301: 1296: 1291: 1286: 1282: 1278: 1273: 1268: 1263: 1258: 1253: 1248: 1243: 1242:) (in rodents) 1233: 1228: 1223: 1218: 1213: 1208: 1203: 1198: 1193: 1188: 1179: 1177: 1166: 1165: 1152: 1150: 1149: 1142: 1135: 1127: 1120: 1119: 1073: 1046:(2): 291ā€“301. 1027: 974: 947:(9): 1831ā€“44. 925: 887: 836: 798: 769:(3): 351ā€“354. 744: 689: 648: 629:(9): 1517ā€“21. 612: 568: 524: 502: 500: 497: 496: 495: 490: 485: 478: 475: 469: 466: 461: 457: 454: 452: 449: 440: 437: 435: 432: 404: 403: 401: 400: 397: 395: 392: 384: 383: 382: 379: 378: 376: 375: 372: 364: 363: 362: 359: 358: 356: 355: 347: 345: 337: 336: 330: 324: 323: 320: 314: 305: 299: 293: 288: 282: 281: 277: 276: 274: 273: 260: 258: 245: 244: 242: 241: 233: 231: 225: 224: 222: 221: 213: 211: 205: 204: 202: 201: 193: 191: 185: 184: 182: 181: 173: 171: 165: 164: 162: 161: 153: 151: 145: 144: 142: 141: 133: 131: 120: 119: 117: 116: 108: 106: 100: 99: 97: 96: 93: 85: 84: 83: 80: 79: 75: 74: 72: 71: 67: 65: 59: 58: 54: 53: 51: 50: 46: 44: 38: 37: 33: 32: 15: 13: 10: 9: 6: 4: 3: 2: 2010: 1999: 1996: 1994: 1991: 1989: 1986: 1984: 1981: 1979: 1976: 1974: 1971: 1969: 1968:PPAR agonists 1966: 1964: 1961: 1960: 1958: 1943: 1942: 1938: 1935: 1934: 1931: 1925: 1922: 1920: 1919:Rivoglitazone 1917: 1915: 1912: 1910: 1909:Netoglitazone 1907: 1905: 1902: 1900: 1897: 1895: 1892: 1890: 1887: 1885: 1882: 1880: 1877: 1874: 1873: 1871: 1869:Non-selective 1867: 1861: 1858: 1855: 1854: 1851: 1848: 1846: 1843: 1841: 1838: 1836: 1833: 1830: 1829: 1826: 1823: 1821: 1818: 1816: 1813: 1811: 1808: 1806: 1803: 1798: 1792: 1791: 1788: 1785: 1783: 1780: 1778: 1775: 1773: 1772:Sodelglitazar 1770: 1768: 1765: 1763: 1760: 1758: 1755: 1753: 1752:Rosiglitazone 1750: 1748: 1747:Rivoglitazone 1745: 1743: 1740: 1738: 1735: 1733: 1727: 1725: 1722: 1720: 1717: 1715: 1712: 1710: 1707: 1705: 1702: 1700: 1699:Netoglitazone 1697: 1695: 1692: 1690: 1687: 1685: 1682: 1680: 1679:Lobeglitazone 1677: 1675: 1672: 1670: 1667: 1665: 1662: 1660: 1657: 1655: 1652: 1650: 1647: 1645: 1642: 1640: 1637: 1635: 1632: 1630: 1627: 1625: 1622: 1620: 1617: 1615: 1612: 1610: 1607: 1605: 1602: 1600: 1597: 1595: 1592: 1590: 1587: 1585: 1582: 1580: 1577: 1575: 1572: 1570: 1567: 1565: 1564:Balaglitazone 1562: 1560: 1557: 1555: 1552: 1550: 1547: 1545: 1542: 1540: 1534: 1532: 1529: 1527: 1524: 1521: 1520: 1518: 1513: 1507: 1501: 1498: 1496: 1493: 1491: 1488: 1485: 1484: 1481: 1478: 1476: 1475:Sodelglitazar 1473: 1471: 1468: 1466: 1463: 1461: 1458: 1456: 1453: 1451: 1448: 1446: 1443: 1441: 1438: 1436: 1433: 1431: 1428: 1426: 1423: 1421: 1418: 1416: 1413: 1411: 1408: 1406: 1403: 1400: 1399: 1397: 1392: 1386: 1380: 1377: 1375: 1372: 1369: 1368: 1365: 1362: 1360: 1357: 1355: 1352: 1350: 1347: 1345: 1344:Sodelglitazar 1342: 1340: 1337: 1335: 1332: 1330: 1327: 1325: 1322: 1320: 1317: 1315: 1312: 1310: 1307: 1305: 1302: 1300: 1299:Lobeglitazone 1297: 1295: 1292: 1290: 1287: 1285: 1281:Leukotriene B 1279: 1277: 1274: 1272: 1269: 1267: 1264: 1262: 1259: 1257: 1254: 1252: 1249: 1247: 1244: 1241: 1237: 1234: 1232: 1229: 1227: 1224: 1222: 1219: 1217: 1214: 1212: 1209: 1207: 1204: 1202: 1199: 1197: 1194: 1192: 1189: 1187: 1184: 1181: 1180: 1178: 1173: 1167: 1163: 1157: 1148: 1143: 1141: 1136: 1134: 1129: 1128: 1125: 1115: 1111: 1107: 1103: 1099: 1095: 1092:(7): 314ā€“21. 1091: 1087: 1086: 1077: 1074: 1069: 1065: 1061: 1057: 1053: 1049: 1045: 1041: 1040: 1031: 1028: 1023: 1019: 1014: 1009: 1004: 999: 995: 991: 990: 985: 978: 975: 970: 966: 962: 958: 954: 950: 946: 942: 941: 932: 930: 926: 921: 917: 913: 909: 906:(1): 90ā€“106. 905: 901: 900: 891: 888: 883: 879: 874: 869: 865: 861: 857: 853: 852: 847: 840: 837: 832: 828: 824: 820: 816: 812: 811: 802: 799: 794: 790: 785: 780: 776: 772: 768: 764: 763: 758: 751: 749: 745: 740: 736: 731: 726: 722: 718: 714: 710: 709: 704: 696: 694: 690: 685: 681: 676: 671: 667: 663: 659: 652: 649: 644: 640: 636: 632: 628: 624: 616: 613: 608: 604: 600: 596: 592: 588: 585:(7): 314ā€“21. 584: 580: 572: 569: 564: 560: 556: 552: 548: 544: 540: 536: 528: 525: 513: 507: 504: 498: 494: 491: 489: 486: 484: 481: 480: 476: 474: 467: 465: 455: 450: 448: 446: 438: 433: 431: 429: 425: 422: 418: 414: 410: 396: 391: 387: 380: 371: 367: 360: 353: 349: 348: 346: 343: 338: 331: 329: 325: 289: 287: 283: 278: 270: 266: 265:DTXSID9040760 262: 261: 259: 250: 246: 239: 235: 234: 232: 230: 226: 219: 215: 214: 212: 210: 206: 199: 195: 194: 192: 190: 186: 179: 175: 174: 172: 170: 166: 159: 155: 154: 152: 150: 146: 139: 135: 134: 132: 125: 121: 114: 110: 109: 107: 105: 101: 92: 88: 81: 76: 69: 68: 66: 64: 60: 55: 48: 47: 45: 43: 39: 36:Clinical data 34: 30: 25: 1993:Fluoroarenes 1939: 1884:Clinofibrate 1879:Ciprofibrate 1875: 1856: 1832:Antagonists: 1831: 1793: 1787:Troglitazone 1782:Tesaglitazar 1767:Sipoglitazar 1762:Saroglitazar 1737:Ragaglitazar 1724:Pioglitazone 1714:Pemaglitazar 1709:Peliglitazar 1694:Naveglitazar 1659:Lanifibranor 1654:Indeglitazar 1609:Edaglitazone 1604:Darglitazone 1584:Cevoglitazar 1522: 1487:Antagonists: 1486: 1460:Lanifibranor 1401: 1371:Antagonists: 1370: 1359:Troglitazone 1349:Tesaglitazar 1339:Saroglitazar 1334:Pioglitazone 1304:Muraglitazar 1276:Lanifibranor 1182: 1089: 1083: 1076: 1043: 1037: 1030: 993: 987: 977: 944: 938: 903: 897: 890: 855: 849: 839: 814: 808: 801: 766: 760: 712: 708:Biochemistry 706: 668:(1): 61ā€“71. 665: 661: 651: 626: 622: 615: 582: 578: 571: 541:(2): 240ā€“9. 538: 534: 527: 515:. Retrieved 506: 471: 459: 442: 434:Pharmacology 416: 412: 408: 407: 63:Legal status 57:Legal status 1914:Ronifibrate 1904:Farglitazar 1894:Englitazone 1777:Telmisartan 1704:Oxeglitazar 1649:Imiglitazar 1629:Farglitazar 1619:Englitazone 1614:Efatutazone 1594:Ciglitazone 1589:Chiglitazar 1579:Cannabidiol 1574:Bezafibrate 1554:Aleglitazar 1430:Elafibranor 1420:Bezafibrate 1319:Pemafibrate 1266:Gemfibrozil 1256:Fenofibrate 1246:Elafibranor 1216:Chiglitazar 1211:Bezafibrate 1196:Aleglitazar 996:: 5625ā€“32. 621:activity". 488:Elafibranor 456:Derivatives 335: gĀ·mol 238:ChEMBL38508 113:317318-84-6 78:Identifiers 1998:Thioethers 1957:Categories 1924:Simfibrate 1899:Etofibrate 1889:Clofibride 1742:Reglitazar 1470:Seladelpar 1435:Fonadelpar 1240:prasterone 1221:Clofibrate 1162:modulators 499:References 340:3D model ( 328:Molar mass 198:4PZK9FJC4Z 169:ChemSpider 149:IUPHAR/BPS 104:CAS Number 87:IUPAC name 1988:Thiazoles 1876:Agonists: 1850:T-0070907 1674:LG-101506 1669:LG-100754 1664:LG-100268 1644:Ibuprofen 1634:Genistein 1569:Berberine 1526:5-Oxo-ETE 1523:Agonists: 1465:LG-101506 1455:L-165,041 1450:GW-501516 1440:Genistein 1402:Agonists: 1294:LG-100754 1289:LG-101506 1261:Genistein 1226:CP-775146 1183:Agonists: 817:: 18ā€“27. 451:Chemistry 1936:See also 1857:Unknown: 1624:Etalocib 1599:Daidzein 1549:15-HpETE 1500:GSK-3787 1495:GSK-0660 1425:Daidzein 1410:15-HpETE 1364:WY-14643 1251:Etomoxir 1231:Daidzein 1191:15-HpETE 1114:25631088 1106:18622687 1068:21168990 1060:20430778 1022:26508837 969:38565637 961:26147382 920:22521259 882:28825467 831:26686607 793:29287957 739:23713684 684:19351742 643:12699745 607:25631088 599:18622687 563:21295375 555:15211590 483:GW501516 477:See also 468:Research 417:fitorine 413:GW610742 42:ATC code 1860:SR-1664 1840:GW-9662 1820:MK-0533 1815:INT-131 1810:EPI-001 1796:SPPARMs 1639:GW-1929 1544:15-HETE 1445:GW-0742 1405:15-HETE 1374:GW-6471 1271:GW-7647 1186:15-HETE 1013:4610778 899:Surgery 873:5643073 784:6008168 730:3724348 424:agonist 421:PPARĪ“/Ī² 419:) is a 286:Formula 178:8110086 138:9934458 124:PubChem 1845:SR-202 1835:FH-535 1825:S26948 1757:RS5444 1689:nTZDpa 1490:FH-535 1379:MK-886 1112:  1104:  1066:  1058:  1020:  1010:  967:  959:  918:  880:  870:  829:  791:  781:  737:  727:  682:  641:  605:  597:  561:  553:  517:31 Mar 409:GW0742 366:SMILES 333:471.48 229:ChEMBL 218:C15625 21:GW0742 1805:BADGE 1511:PPARĪ³ 1390:PPARĪ“ 1171:PPARĪ± 1110:S2CID 1064:S2CID 965:S2CID 603:S2CID 559:S2CID 386:InChI 342:JSmol 1236:DHEA 1155:PPAR 1102:PMID 1056:PMID 1018:PMID 957:PMID 916:PMID 878:PMID 827:PMID 789:PMID 735:PMID 680:PMID 639:PMID 595:PMID 551:PMID 519:2013 415:and 209:KEGG 189:UNII 158:2686 49:None 1094:doi 1048:doi 1008:PMC 998:doi 949:doi 908:doi 904:152 868:PMC 860:doi 819:doi 815:122 779:PMC 771:doi 725:PMC 717:doi 670:doi 631:doi 587:doi 543:doi 445:VDR 254:EPA 128:CID 1959:: 1108:. 1100:. 1090:57 1088:. 1062:. 1054:. 1044:88 1042:. 1016:. 1006:. 992:. 986:. 963:. 955:. 945:33 943:. 928:^ 914:. 902:. 876:. 866:. 856:19 854:. 848:. 825:. 813:. 787:. 777:. 767:28 765:. 759:. 747:^ 733:. 723:. 713:52 711:. 705:. 692:^ 678:. 666:83 664:. 660:. 637:. 627:13 625:. 601:. 593:. 583:57 581:. 557:. 549:. 539:77 537:. 462:50 430:. 300:17 294:21 1802:: 1731:2 1538:2 1283:4 1238:( 1146:e 1139:t 1132:v 1116:. 1096:: 1070:. 1050:: 1024:. 1000:: 994:9 971:. 951:: 922:. 910:: 884:. 862:: 833:. 821:: 795:. 773:: 741:. 719:: 686:. 672:: 645:. 633:: 609:. 589:: 565:. 545:: 521:. 344:) 321:2 318:S 315:3 312:O 309:N 306:4 303:F 297:H 291:C 256:) 252:(

Index


ATC code
Legal status
IUPAC name
CAS Number
317318-84-6
PubChem
9934458
IUPHAR/BPS
2686
ChemSpider
8110086
UNII
4PZK9FJC4Z
KEGG
C15625
ChEMBL
ChEMBL38508
CompTox Dashboard
DTXSID9040760
Edit this at Wikidata
Formula
Molar mass
JSmol
Interactive image
SMILES
InChI
PPARĪ“/Ī²
agonist
GlaxoSmithKline

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

ā†‘